---
title: "This Arxis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285953353.md"
description: "Top Wall Street analysts have initiated coverage on several companies with varying ratings and price targets. Goldman Sachs analyst Noah Poponak rated Arxis Inc (NASDAQ:ARXS) as Buy with a price target of $53. Other notable initiations include Madison Air Solutions (NYSE:MAIR) with an Outperform rating and a $48 target, BridgeBio Oncology (NASDAQ:BBOT) with a Buy rating and a $23 target, Live Oak Acquisition (NASDAQ:LOKV) with a Buy rating and a $13.5 target, and Oklo Inc (NYSE:OKLO) with a Neutral rating and an $83 target."
datetime: "2026-05-11T13:31:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285953353.md)
  - [en](https://longbridge.com/en/news/285953353.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285953353.md)
---

# This Arxis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

-   Baird analyst Timothy Wojs initiated coverage on **Madison Air Solutions** (NYSE:MAIR) with an Outperform rating and announced a price target of $48. Madison Air Solutions shares closed at $42.02 on Friday. See how other analysts view this stock.
-   Goldman Sachs analyst Noah Poponak initiated coverage on **Arxis Inc** (NASDAQ:ARXS) with a Buy rating and announced a price target of $53. Arxis shares closed at $35.10 on Friday. See how other analysts view this stock.
-   Canaccord Genuity analyst John Newman initiated coverage on **BridgeBio Oncology Therapeutics Inc** (NASDAQ:BBOT) with a Buy rating and announced a price target of $23. BridgeBio Oncology shares closed at $7.66 on Friday. See how other analysts view this stock.
-   Compass Point analyst Giuliano Bologna initiated coverage on **Live Oak Acquisition Corp V** (NASDAQ:LOKV) with a Buy rating and announced a price target of $13.5. Live Oak Acquisition shares closed at $10.46 on Friday. See how other analysts view this stock.
-   JP Morgan analyst Jeremy Tonet initiated coverage on **Oklo Inc** (NYSE:OKLO) with a Neutral rating and announced a price target of $83. Oklo shares closed at $72.51 on Friday. See how other analysts view this stock.

Considering buying ARXS stock? Here’s what analysts think:

_Photo via Shutterstock_

### Related Stocks

- [ARXS.US](https://longbridge.com/en/quote/ARXS.US.md)
- [LOKV.US](https://longbridge.com/en/quote/LOKV.US.md)
- [MAIR.US](https://longbridge.com/en/quote/MAIR.US.md)
- [BBOT.US](https://longbridge.com/en/quote/BBOT.US.md)
- [OKLO.US](https://longbridge.com/en/quote/OKLO.US.md)
- [LOKVU.US](https://longbridge.com/en/quote/LOKVU.US.md)
- [LOKVW.US](https://longbridge.com/en/quote/LOKVW.US.md)

## Related News & Research

- [Oklo Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call](https://longbridge.com/en/news/286104154.md)
- [Oklo plunges 6%: why this analyst is cautious on the stock](https://longbridge.com/en/news/286944506.md)
- [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md)
- [This Interface Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday](https://longbridge.com/en/news/286923370.md)
- [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md)